
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the advantage of novel oral anticoagulants over vitamin K antagonists.
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the advantage of novel oral anticoagulants over vitamin K antagonists.
This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.






